Taken together, these results reveal a FMRP-dependent neuron-to-glia intercellular signaling pathway triggering glial phagocytic developmental remodeling of central brain neural circuitry, suggesting putative therapeutic targets for the FXS neurodevelopmental disorder. The gene discussed is FMR1; the disease is fragile X syndrome.